XML 43 R26.htm IDEA: XBRL DOCUMENT
v3.21.2

Summary of Significant Accounting Policies (Details) | 12 Months Ended
--- | ---
Sep. 30, 2021 USD ($)
Summary of Significant Accounting Policies (Details) [Line Items] |
Research and development expenses | $ 19,400,000
Dr. Reddy’s [Member] |
Summary of Significant Accounting Policies (Details) [Line Items] |
Research and development expenses | $ 40,000,000

X
- References No definition available. + Details
Name: | ctxr_SummaryofSignificantAccountingPoliciesDetailsLineItems
Namespace Prefix: | ctxr_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of other research and development expense. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 730 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373 + Details
Name: | us-gaap_OtherResearchAndDevelopmentExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=ctxr_DrReddysMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |